Ligand Pharmaceuticals
LGND
#4056
Rank
C$3.24 B
Marketcap
$171.63
Share price
-1.10%
Change (1 day)
73.07%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.11

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.23. In 2022 the company made an earnings per share (EPS) of -$2.82 a decrease over its 2021 EPS that were of $4.92.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.11-175.09%
2022-$2.82-157.23%
2021$4.92-2571.43%
2020-$0.20-100.46%
2019$43.54353.48%
2018$9.601025%
2017$0.85-700%
2016-$0.14-100.87%
2015$16.441859.32%
2014$0.845.36%
2013$0.808.0704505322479E+18%
2012$0.0000000000-100%
2011$0.70-194.23%
2010-$0.74548.38%
2009-$0.11-98.7%
2008-$8.79-136.52%
2007$24.07-787.8%
2006-$3.50-14.58%
2005-$4.10-21.31%
2004-$5.21-55.15%
2003-$11.6181.33%
2002-$6.402.74%
2001-$6.23-45.93%
2000-$11.52-14.56%
1999-$13.48-45.52%
1998-$24.75-3.97%
1997-$25.77132.31%
1996-$11.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$20.13 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.51-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.98 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.59 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.65 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.72 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.65 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.28 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.03 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA